share_log

Avalo Therapeutics | 424B5: Prospectus

SEC announcement ·  Jun 8, 2020 16:03
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more